Cargando…

Prognostic Nomogram for Overall Survival of Patients Aged 50 Years or Older with Cervical Cancer

OBJECTIVE: The prognostic factors of cervical cancer in elderly patients have not been researched systematically. We aimed to investigate the clinicopathological characteristics of patients with cervical cancer aged ≥50 years and establish a nomogram for evaluating their prognoses for overall surviv...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Jing, He, Yue, Wang, Ming, Wu, Yumei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579836/
https://www.ncbi.nlm.nih.gov/pubmed/34785932
http://dx.doi.org/10.2147/IJGM.S335409
_version_ 1784596504062722048
author Yan, Jing
He, Yue
Wang, Ming
Wu, Yumei
author_facet Yan, Jing
He, Yue
Wang, Ming
Wu, Yumei
author_sort Yan, Jing
collection PubMed
description OBJECTIVE: The prognostic factors of cervical cancer in elderly patients have not been researched systematically. We aimed to investigate the clinicopathological characteristics of patients with cervical cancer aged ≥50 years and establish a nomogram for evaluating their prognoses for overall survival. METHODS: From the Surveillance, Epidemiology, and End Results database, we obtained data of 8538 patients with pathology-confirmed cervical cancer between 2004 and 2015. Patients were divided into training (n = 5941) and validation (n = 2597) cohorts. A nomogram was constructed to evaluate the prognostic prediction value for disease progression. The concordance index, receiver operating characteristic curve, and calibration chart were used to evaluate the model’s prediction accuracy and discriminative ability. Survival condition was analyzed using the Kaplan–Meier method. RESULTS: In the training cohort, age at diagnosis, race, histology, grade, stage, tumor size, number of examined lymph nodes, and treatment significantly correlated with outcome and were used to develop the nomogram. The calibration curve for survival probability showed an excellent agreement between the nomogram-predicted and actual survival in the training cohort. CONCLUSION: Our nomogram has less bias and gives better accuracy than the International Federation of Gynecology and Obstetrics staging system and can help set up a more individualized feasible follow-up plan.
format Online
Article
Text
id pubmed-8579836
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-85798362021-11-15 Prognostic Nomogram for Overall Survival of Patients Aged 50 Years or Older with Cervical Cancer Yan, Jing He, Yue Wang, Ming Wu, Yumei Int J Gen Med Original Research OBJECTIVE: The prognostic factors of cervical cancer in elderly patients have not been researched systematically. We aimed to investigate the clinicopathological characteristics of patients with cervical cancer aged ≥50 years and establish a nomogram for evaluating their prognoses for overall survival. METHODS: From the Surveillance, Epidemiology, and End Results database, we obtained data of 8538 patients with pathology-confirmed cervical cancer between 2004 and 2015. Patients were divided into training (n = 5941) and validation (n = 2597) cohorts. A nomogram was constructed to evaluate the prognostic prediction value for disease progression. The concordance index, receiver operating characteristic curve, and calibration chart were used to evaluate the model’s prediction accuracy and discriminative ability. Survival condition was analyzed using the Kaplan–Meier method. RESULTS: In the training cohort, age at diagnosis, race, histology, grade, stage, tumor size, number of examined lymph nodes, and treatment significantly correlated with outcome and were used to develop the nomogram. The calibration curve for survival probability showed an excellent agreement between the nomogram-predicted and actual survival in the training cohort. CONCLUSION: Our nomogram has less bias and gives better accuracy than the International Federation of Gynecology and Obstetrics staging system and can help set up a more individualized feasible follow-up plan. Dove 2021-11-06 /pmc/articles/PMC8579836/ /pubmed/34785932 http://dx.doi.org/10.2147/IJGM.S335409 Text en © 2021 Yan et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Yan, Jing
He, Yue
Wang, Ming
Wu, Yumei
Prognostic Nomogram for Overall Survival of Patients Aged 50 Years or Older with Cervical Cancer
title Prognostic Nomogram for Overall Survival of Patients Aged 50 Years or Older with Cervical Cancer
title_full Prognostic Nomogram for Overall Survival of Patients Aged 50 Years or Older with Cervical Cancer
title_fullStr Prognostic Nomogram for Overall Survival of Patients Aged 50 Years or Older with Cervical Cancer
title_full_unstemmed Prognostic Nomogram for Overall Survival of Patients Aged 50 Years or Older with Cervical Cancer
title_short Prognostic Nomogram for Overall Survival of Patients Aged 50 Years or Older with Cervical Cancer
title_sort prognostic nomogram for overall survival of patients aged 50 years or older with cervical cancer
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579836/
https://www.ncbi.nlm.nih.gov/pubmed/34785932
http://dx.doi.org/10.2147/IJGM.S335409
work_keys_str_mv AT yanjing prognosticnomogramforoverallsurvivalofpatientsaged50yearsorolderwithcervicalcancer
AT heyue prognosticnomogramforoverallsurvivalofpatientsaged50yearsorolderwithcervicalcancer
AT wangming prognosticnomogramforoverallsurvivalofpatientsaged50yearsorolderwithcervicalcancer
AT wuyumei prognosticnomogramforoverallsurvivalofpatientsaged50yearsorolderwithcervicalcancer